Keyword search (4,163 papers available)

"Greco BM" Authored Publications:

Title Authors PubMed ID
1 PARPAL: PARalog Protein Redistribution using Abundance and Localization in Yeast Database Greco BM; Zapata G; Dandage R; Papkov M; Pereira V; Lefebvre F; Bourque G; Parts L; Kuzmin E; 40580499
BIOLOGY
2 Single-cell imaging of protein dynamics of paralogs reveals sources of gene retention Dandage R; Papkov M; Greco BM; Pereira V; Fishman D; Friesen H; Wang K; Styles EB; Kraus O; Grys B; Zapata G; Lefebvre F; Bourque G; Boone C; Andrews BJ; Parts L; Kuzmin E; 40585364
BIOLOGY
3 A Humanized Yeast Model for Studying TRAPP Complex Mutations; Proof-of-Concept Using Variants from an Individual with a TRAPPC1-Associated Neurodevelopmental Syndrome Zykaj E; Abboud C; Asadi P; Warsame S; Almousa H; Milev MP; Greco BM; López-Sánchez M; Bratkovic D; Kachroo AH; Pérez-Jurado LA; Sacher M; 39273027
BIOLOGY
4 Single-cell imaging of protein dynamics of paralogs reveals mechanisms of gene retention Dandage R; Papkov M; Greco BM; Fishman D; Friesen H; Wang K; Styles E; Kraus O; Grys B; Boone C; Andrews B; Parts L; Kuzmin E; 38045359
BIOLOGY
5 Rapid, scalable, combinatorial genome engineering by marker-less enrichment and recombination of genetically engineered loci in yeast Abdullah M; Greco BM; Laurent JM; Garge RK; Boutz DR; Vandeloo M; Marcotte EM; Kachroo AH; 37323580
BIOLOGY
6 Humanized yeast to model human biology, disease and evolution Kachroo AH; Vandeloo M; Greco BM; Abdullah M; 35661208
BIOLOGY

 

Title:A Humanized Yeast Model for Studying TRAPP Complex Mutations; Proof-of-Concept Using Variants from an Individual with a TRAPPC1-Associated Neurodevelopmental Syndrome
Authors:Zykaj EAbboud CAsadi PWarsame SAlmousa HMilev MPGreco BMLópez-Sánchez MBratkovic DKachroo AHPérez-Jurado LASacher M
Link:https://pubmed.ncbi.nlm.nih.gov/39273027/
DOI:10.3390/cells13171457
Publication:Cells
Keywords:GolgiTRAPPTRAPPC1autophagyhumanizationmutationyeast
PMID:39273027 Category: Date Added:2024-09-14
Dept Affiliation: BIOLOGY
1 Department of Biology, Concordia University, Montreal, QC H4B1R6, Canada.
2 Department of Medicine and Life Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
3 Hospital del Mar, Hospital del Mar Research Institute (IMIM), 08003 Barcelona, Spain.
4 Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, 28029 Madrid, Spain.
5 Women's and Children's Hospital, Metabolic Clinic, North Adelaide, SA 5006, Australia.
6 Department of Anatomy and Cell Biology, McGill University, Montreal, QC H3A 0C7, Canada.

Description:

Variants in membrane trafficking proteins are known to cause rare disorders with severe symptoms. The highly conserved transport protein particle (TRAPP) complexes are key membrane trafficking regulators that are also involved in autophagy. Pathogenic genetic variants in specific TRAPP subunits are linked to neurological disorders, muscular dystrophies, and skeletal dysplasias. Characterizing these variants and their phenotypes is important for understanding the general and specialized roles of TRAPP subunits as well as for patient diagnosis. Patient-derived cells are not always available, which poses a limitation for the study of these diseases. Therefore, other systems, like the yeast Saccharomyces cerevisiae, can be used to dissect the mechanisms at the intracellular level underlying these disorders. The development of CRISPR/Cas9 technology in yeast has enabled a scar-less editing method that creates an efficient humanized yeast model. In this study, core yeast subunits were humanized by replacing them with their human orthologs, and TRAPPC1, TRAPPC2, TRAPPC2L, TRAPPC6A, and TRAPPC6B were found to successfully replace their yeast counterparts. This system was used for studying the first reported individual with an autosomal recessive disorder caused by biallelic TRAPPC1 variants, a girl with a severe neurodevelopmental disorder and myopathy. We show that the maternal variant (TRAPPC1 p.(Val121Alafs*3)) is non-functional while the paternal variant (TRAPPC1 p.(His22_Lys24del)) is conditional-lethal and affects secretion and non-selective autophagy in yeast. This parallels defects seen in fibroblasts derived from this individual which also showed membrane trafficking defects and altered Golgi morphology, all of which were rescued in the human system by wild-type TRAPPC1. This study suggests that humanized yeast can be an efficient means to study TRAPP subunit variants in the absence of human cells and can assign significance to variants of unknown significance (VUS). This study lays the foundation for characterizing further TRAPP variants through this system, rapidly contributing to disease diagnosis.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University